Mucogenix™
Mucoadhesive sublingual and buccal delivery. Sustained mucosal contact of eight to twelve hours via bioadhesive polymer.
NutraceuticalAestheticSportsLongevity
Capabilities
Every consumer route. Trade-named. Patented.
Atumnus Life Sciences holds a portfolio of trade-named, patented peptide-class compounds and Opti-Salt™ therapeutic salt carriers for the Opticeutical category — covering every consumer route of administration across oral, mucosal, skin, microneedle, personalized, smart-connected, veterinary, and agricultural delivery.
The Problem with Category IP
Most bioregulator IP covers a single compound, a single route, or a single layer of the stack. A category requires more.
Formula patents without delivery coverage leak through every alternative route. Delivery technology without the underlying composition is unbranded science. Trade names without either are marketing. The defensible position requires the full stack — composition, formulation, manufacturing, delivery, administration, combination architecture, and operational AI — and it requires that delivery work across every route a consumer actually uses.
The Atumnus portfolio is built on this premise. Thirteen trade-named delivery platforms across four functional domains, organized around the seven layers of IP coverage that define a defensible category position. The breadth is not redundant. A category that can only be delivered one way is not a category — it is a product.
Domain 01
Oral & Mucosal
Sublingual, buccal, and oral routes — including the comprehensive enteric format suite that underlies the consumer supplement category.
Sublingix™
Full sublingual format suite. Powder, sachet, fast-dissolve tablet, film, strip, lozenge, troche, and metered-dose spray.
NutraceuticalAestheticSportsVeterinary
Oral & Enteric
Capsule, tablet, sachet, stick pack, chewable, fast-dissolve, enteric-coated, delayed-release, gastro-retentive, and mucoadhesive intestinal formats.
NutraceuticalFunctional foodBeverageVeterinary
Domain 02
Skin Delivery
Five distinct skin-delivery technologies covering passive permeation, energy-assisted enhancement, microneedle penetration, and intradermal medspa application.
Dermatrix™
Transdermal patches and serums. Cream, gel, serum, and patch with permeation enhancer or microneedle integration.
AestheticCosmeticSportsVeterinary
Microgenix™
Microneedle patches. Dissolving, coated, hollow, swellable, and core-shell programmed-release. Weeks-to-months sustained delivery from a single application.
AestheticSportsVeterinary
Iontogenix™
Iontophoresis — electrical-field-assisted transdermal delivery at 0.1 to 0.5 mA per cm².
Aesthetic medspaSports rehab
Sonogenix™
Sonophoresis — ultrasound-assisted transdermal delivery. Low-frequency 20–100 kHz and high-frequency 0.7–3 MHz.
Aesthetic medspaSports rehab
Mesogenix™
Mesotherapy intradermal — a medspa application format for skin rejuvenation, hair restoration, and cellulite applications.
Aesthetic medspaCosmetic
Domain 03
Smart & Personalized
Next-generation delivery. 3D-printed personalization, sensor-equipped smart delivery, and nanocarrier hybrid systems.
Printgenix™
3D-printed personalized supplements. Personalized to genetic profile, microbiome, age, weight, or wellness goal. Multi-compartment formats with tactile imprinting and QR-code embedding.
Personalized wellnessAesthetic personalizedSubscription DTC
Smartgenix™
Smart connected delivery. Sensor-equipped devices, app-paired tracking, and biomarker-driven adjustment.
Longevity clinicAesthetic medspaSubscription DTC
Liposogenix™ / Polymergenix™ / Exogenix™ / Hydrogenix™
Nanocarrier-Opti-Salt™ hybrid delivery. Liposomal, polymeric nanoparticle, exosomal, and hydrogel-based platforms.
AestheticCosmeticSports recovery
Domain 04
Veterinary & Agricultural
Delivery platforms engineered for animal health and agricultural application — distinct regulatory frameworks, substantial markets in their own right.
Veterinary Delivery Suite
Hydrophilic films, transmucosal sprays, palatability matrices (chicken, beef, salmon, peanut butter, cheese, molasses, apple, tuna, liver), feed coatings, water additives, and dart-delivered formats.
CompanionEquineLivestockPoultryWildlifeZoo
Agricultural & Aquacultural
Foliar sprays, soil drenches, seed coatings, root dips, hydroponic delivery, water dispersion, feed coating, and hatchery application.
AgriculturalAquaculturalApicultural
The Reach
Every consumer vertical the platforms serve.
The delivery portfolio spans wellness, beauty, sports, veterinary, and agricultural verticals. Each is a substantial market in its own right. The same underlying platform technology adapts across them.
Consumer Wellness
- Nutraceutical
- Functional food
- Beverage
- Subscription DTC
- Personalized wellness
Beauty & Aesthetic
- Aesthetic
- Cosmetic
- Medspa
- Aesthetic personalized
Sports & Performance
- Sports
- Sports recovery
- Sports rehab
- Longevity
Veterinary
- Companion
- Equine
- Livestock
- Poultry
- Wildlife
- Zoo
Agricultural
- Agricultural
- Aquacultural
- Apicultural
Intellectual Property
A comprehensive intellectual property portfolio built on bioregulator science.
Atumnus Life Sciences holds a portfolio of issued patents, patent-pending applications, and registered and pending trademarks across the disciplines required to bring an Opticeutical to market — from the underlying compounds through manufacturing, formulation, delivery, administration, and proprietary AI infrastructure.
The trade names visible across this page are part of a broader trademark portfolio spanning compositions, delivery platforms, carrier systems, and category designations.
Compound trade names
Seven named peptide-class bioregulator compositions
Delivery platform names
Across every consumer route of administration
Therapeutic salt carriers
Opti-Salt™ and related carrier-chemistry nomenclature
Category designations
The Opticeutical name and adjacent class marks
Areas of Coverage
- 01
Composition of matter
Intellectual property coverage on the underlying short-chain peptide compounds identified by the trade names on this page.
- 02
Formulation
Stabilization chemistry, polymorph selection, and proprietary carrier system technology.
- 03
Manufacturing
Synthesis routes, particle engineering, crystallization control, and process methods.
- 04
Delivery
The trade-named platforms shown above — covering every consumer route of administration.
- 05
Administration
Dosing approaches, cycling protocols, and personalization methods.
- 06
Combination architecture
Multi-bioregulator stacking and adjunct-ingredient combination methods.
- 07
AI infrastructure
Proprietary discovery, personalization, and partner-facing operational systems.
Qualified partners and capital partners may request access to the intellectual property overview through the contact channel.
Framing
On capabilities versus products.
The trade names listed above identify patented compounds developed and held by Atumnus Life Sciences. The platforms shown on this page are the consumer-facing portfolio. Additional platforms in the broader Atumnus portfolio fall outside the Opticeutical category framework and are not displayed here.
Listing of a compound on this page does not constitute the availability of any specific product for any specific use. Trade names referenced here are trademarks of Atumnus Life Sciences. Underlying compositions are protected by issued patents and pending applications.
Partnership & Licensing
The portfolio is patented. The opportunity is partnership.
Manufacturing licensees, distribution channels, brand partners, and capital partners interested in deploying the portfolio across specific verticals. Direct channel to Atumnus Life Sciences as steward.